Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1985-06-06
1988-08-02
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514 89, 514107, A61K 3166, A61K 31675
Patent
active
047614064
ABSTRACT:
A method for treating or preventing osteoporosis utilizing a cyclic regimen comprising alternating for two or more cycles the administration of a bone resorption inhibiting polyphosphonate and a no treatment (rest) period. Further disclosed is a kit for use in implementing this method of treatment.
REFERENCES:
patent: 3683080 (1972-08-01), Francis
patent: 4054598 (1977-10-01), Blum et al.
patent: 4230700 (1980-10-01), Francis
patent: 4330537 (1982-05-01), Francis
Chesnut, "Synthetic Salmon Calcitonin, Diphosphonates, and Anabolic Steroids in the Treatment of Postmenopausal Osteoporosis", Osteoporosis-Proceedings of the Copenhagen International Symposium on Osteoporosis, Jun. 3-8, 1984, (Christiansen et al., Editors), Aalborg Stiftsbogtrykkeri (1984), pp. 549-555, see pp. 551-552.
Adami et al., "Dichloromethylene-Disphosphonate Therapy of Osteolytic Lesions and Osteoporosis", Osteoporosis-Proceedings of the Copenhagen International Symposium on Osteoporosis, Jun. 3-8, 1984, (Christiansen et al., Editors), Aalborg Stiftsbogtrykkeri (1984), pp. 643-645.
Reeve et al., "Studies of a `Short-Cycle` ADFR Regime Using Parathyroid Peptide hPTH 1-34 in Idiopathic Osteoporosis and in a Dog Model," Osteoporosis-Proceedings of the Copenhagen International Symposium on Osteoporosis, Jun. 3-8, 1984, (Christiansen et al., Editors), Aalborg Stiftsbogtrykkeri (1984), pp. 567-573.
Rasmussen et al., "Effect of Combined Therapy with Phosphate and Calcitonin on Bone Volume in Osteoporosis," Metab. Bone Dis. & Rel. Res., vol. 2, (1980), pp. 107-111.
Rasmussen, "Considerations as to the Pathogenesis and Treatment of Osteoporosis" in Bone Histomorphometry 1980, (Jee and Parifitt Editors), Armour-Montagu, Levallois, (1981), pp. 311-316.
Marie et al., "Treatment of Postmenopausal Osteoporosis with Phosphate and Intermittent Calcitonin", Osteoporosis-Proceedings of the Copenhagen International Symposium on Osteoporosis, Jun. 3-8, 1984, (Christiansen et al., Editors), Aalborg Stiftsbogtrykkeri, (1984), pp. 575-579.
Berthel et al., "Treatment of Post Menopausal Osteoporosis with Phosphate and Intermittent Calcitonin: Effect on Cortical Bone", Osteoporosis-Proceedings of the Copenhagen International Symposium on Osteoporosis, Jun. 3-8, 1984, (Christiansen et al., Editors), Aalborg Stiftsbogtrykkeri, (1984), pp. 651-652.
Ortolani et al., "Treatment of Postmenopausal and Senile Osteoporosis with Combined Calcitonin and 1.25-Dihydroxycholecalciterol", Osteoporosis-Proceedings of the Copenhagen International Symposium on Osteoporosis, Jun. 3-8, 1984, (Christiansen et al., Editors), Aalborg Stiftsbogtrykkeri, (1984), pp. 625-628.
Geusen and Dequeker, "Effect of Anabolic Steriods, 1-alpha Hydroxyvitamin D and Intermittent Calcium Infusions on Bone Mineral Content in Osteoporosis," pp. 665-667, Osteoporosis-Proceedings of the Copenhagen International Symposium on Osteoporosis, Jun. 3-8, 1984, (Christiansen et al., Editors), Aalborg Stiftsbogtrykkeri, (1984).
Delmas et al., "Cyclic Fluoride Therapy for Postmenopausal Osteoporosis", Osteoporosis-Proceedings of the Copenhagen International Symposium on Osteoporosis, Jun. 3-8, 1984, (Christiansen et al., Editors), Aalborg Stiftsbogtrykkeri, (1984), pp. 581-586.
Meunier et al., "Treatment of Primary Osteoporosis with Drugs that Increase Bone Formation: Sodium Fluoride, hPTH 1-34, ADFR Concept," Osteoporosis-Proceedings of the Copenhagen International Symposium on Osteoporosis, Jun. 3-8, 1984, (Christiansen et al., Editors), Aalborg Stiftsbogtrykkeri, (1984), pp. 595-602.
Kleerekoper et al., "Treatment of Osteoporosis with Sodium Fluoride Alternating with Calcium and Vitamin D", Osteoporosis: Recent Advances in Pathogenesis and Treatment, (DeLuca et al., Editors), University Park Press, Baltimore, MD, (1981), pp. 441-448.
Briancon and Meunier, "Treatment of Osteoporosis with Fluoride, Calcium, and Vitamin D", Orthop. Clin. N. Amer., vol. 12, (1981), pp. 629-648.
Siris et al., "Long-Term Therapy of Paget's Disease of Bone with EHDP", Arthritis and Rheumatism, 23(10), pp. 1177-1184, (1980).
Meunier et al., "Effects of Disodium Dichloromethylene Diphosphonate on Paget's Disease of Bone," Adv. Exp. Med. Biol., 128, pp. 299-309, (1980).
Anderson et al., "Preliminary Observations of a Form of Coherence Therapy for Osteoporosis", Calcif. Tissue Int., vol. 36, (1984), pp. 341-343.
Frost, "Editorial--the ADFR Concept Revisited", Calcif. Tissue Int., vol. 36, (1984), pp. 349-353.
Recker, "Stimulation of New Bone Formation by the `ADFR` Technique in Dogs", in Bone Histomorphometry 1980, (Jee and Parifitt Editors), Armour-Montagu, Levallois, (1981), pp. 331-336.
Bonjour et al., "Action of 1,25-Dihydroxyvitamin D.sub.3 and a Diphosphonate in Calcium Metabolism in Rats", Amer. J. Physiology, vol. 229, (1975), pp. 402-408.
Bonjour et al., "Influence of 1,25-Dihydroxycholecalciferol and Diphosphonate on Calcium Metabolism", Experientia, vol. 29, (1973), p. 740.
Boris et al., "Evidence for the Promotion of Bone Mineralization by 1-alpha, 25-Dihydroxycholecalciferol in the Rat Unrelated to the Correction of Deficiencies in Serum Calcium and Phosphorus", J. Nutr., vol. 108 (1978), pp. 1899-1906.
Boris, et al., "Effect of Diphosphonates on Bone Mineralization and Serum Levels of 1-alpha, 25-Dihydroxyvitamin D in Rats," Proceedings of the Workshop on Vitamin D, 1982, pp. 809-811, (1982).
Boris, et al., "Effect of Diphosphonates on Bone Mineralization and Serum Levels of 1-alpha. 25-Dihydroxyvitamin D in Rats", Abstract from the Fifth Workshop on Vitamin D, Historic Williamsburg, Virginia, Feb. 14-19, 1982.
Frost, "Treatment of Osteoporosis by Manipulation of Coherent Bone Cell Populations Clin. Orth. Rel. Res., vol. 143, (1979), pp. 227-244.
Frost, "The ADFR Concept and Monitoring It", in Bone Histomorphometry 1980, (Jee and Parifitt Editors), Armour-Montagu, Levallois, (1981), pp. 317-321.
Frost, "The Evolution of Osteoporosis Therapy", Orthop. Clin. N. Amer., vol. 12, (1981), pp. 603-610.
Frost, "Coherence Treatment of Osteoporoses", Orthop. Clin. N. Amer., vol. 12, (1981), pp. 649-669.
Frost, "Clinical Management of the Symptomatic Osteoporotic Patient", Orthop. Clin. N. Amer., vol. 12, (1981), pp. 671-681.
Frost, "Osteoporoses: Quo Vadis", Orthop. Clin. N. Amer., vol. 12, (1981), pp. 683-691.
Frost, "Review Article--The Skeletal Intermediary Organization", Metab. Bone Dis. & Rel. Res., vol. 4, (1983), pp. 281-290.
Francis and Martodam, "CH. 4-Chemical, Biochemical, and Medicinal Properties of the Diphosphonates," in The Role of Phosphonates in Living Systems, (Hildebrand, Editor), CRC Press, Inc., Boca Raton, Fla., (1983), pp. 55-96.
Recker, "Continuous Treatment of Osteoporosis: Current Status", Orthop. Clin. N. Amer., vol. 12, (1981), pp. 611-627.
Flora Lawrence
Floyd Benjamin F.
Friedman Stanley J.
Goldstein Steven J.
Graff IV Milton B.
Schaeffer Jack D.
The Procter & Gamble & Company
LandOfFree
Regimen for treating osteoporosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regimen for treating osteoporosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regimen for treating osteoporosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-711922